Arcutis Biotherapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -136.65M-206.36M-311.46M-262.14M-140.04M
Depreciation and Depletion 0.07M0.12M0.50M0.62M0.80M0.64M
Share-based Compensation 0.15M0.82M7.94M23.89M32.68M38.81M41.73M
Gains from Investment Securities 0.39M3.62M
Cash from Operations -14.09M-42.84M-113.03M-174.63M-257.71M-247.06M-112.16M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.35M0.33M-3.45M2.25M6.99M6.90M
Amortization of Deferred Charges 2.61M4.03M5.40M
Depreciation & Amortization (CF) 0.07M0.12M0.50M0.62M0.80M0.64M
Change in Working Capital
Change in Receivables 8.46M17.35M47.26M
Change in Inventory 7.51M5.62M0.40M
Change in Account Payables 1.26M-0.46M5.67M0.24M1.56M3.15M2.23M
Change in Accured Expenses 0.60M2.39M11.88M10.46M1.19M5.59M32.03M
Other Working Capital Changes -0.24M3.30M3.41M7.33M-3.47M8.62M0.95M
Investing Activities
Capital Expenditures 0.29M0.32M0.99M0.33M0.43M0.14M
Change in Intangibles 7.50M5.00M
Change in Acquisitions & Divestments 34.80M97.60M217.55M351.47M406.50M288.78M
Cash from Investing Activities -11.53M-26.32M-181.82M-75.95M-87.20M180.23M28.82M
Financing Activities
Other financing activities 1.64M2.19M
Cash from Financing Activities 61.59M93.10M298.14M281.95M301.80M101.32M66.20M
Additional items
Exchange Rate Effect -0.05M-0.23M
Change in Cash 35.98M23.94M3.29M31.37M-43.12M34.45M-17.37M
Free Cash Flow -14.09M-43.13M-113.35M-175.62M-258.05M-247.49M-112.30M
Net Cash Flow 35.98M23.94M3.29M31.37M-43.12M34.50M-17.14M